SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

NYSE:SEM • US81619Q1058

16.25 USD
-0.01 (-0.06%)
At close: Mar 4, 2026
16.25 USD
0 (0%)
After Hours: 3/4/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SEM. SEM was compared to 101 industry peers in the Health Care Providers & Services industry. While SEM is still in line with the averages on profitability rating, there are concerns on its financial health. SEM is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. SEM Profitability Analysis

1.1 Basic Checks

  • In the past year SEM was profitable.
  • In the past year SEM had a positive cash flow from operations.
  • In the past 5 years SEM has always been profitable.
  • In the past 5 years SEM always reported a positive cash flow from operatings.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • SEM has a Return On Assets (2.44%) which is in line with its industry peers.
  • SEM has a Return On Equity of 8.38%. This is in the better half of the industry: SEM outperforms 66.34% of its industry peers.
  • SEM's Return On Invested Capital of 5.27% is in line compared to the rest of the industry. SEM outperforms 56.44% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SEM is below the industry average of 9.13%.
  • The last Return On Invested Capital (5.27%) for SEM is above the 3 year average (4.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SEM has a better Profit Margin (2.62%) than 64.36% of its industry peers.
  • In the last couple of years the Profit Margin of SEM has declined.
  • SEM has a Operating Margin of 6.17%. This is in the better half of the industry: SEM outperforms 69.31% of its industry peers.
  • SEM's Operating Margin has declined in the last couple of years.
  • SEM has a worse Gross Margin (11.54%) than 71.29% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SEM Health Analysis

2.1 Basic Checks

  • SEM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SEM has been reduced compared to 1 year ago.
  • Compared to 5 years ago, SEM has less shares outstanding
  • Compared to 1 year ago, SEM has a worse debt to assets ratio.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.62. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • SEM has a Altman-Z score (1.62) which is in line with its industry peers.
  • The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
  • SEM has a Debt to FCF ratio of 15.74. This is comparable to the rest of the industry: SEM outperforms 42.57% of its industry peers.
  • SEM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • SEM has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: SEM underperforms 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.62
ROIC/WACC0.65
WACC8.07%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.04, SEM is doing worse than 67.33% of the companies in the same industry.
  • SEM has a Quick Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.04, SEM is in line with its industry, outperforming 41.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SEM Growth Analysis

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • The Earnings Per Share has been decreasing by -9.36% on average over the past years.
  • The Revenue has been growing slightly by 5.12% in the past year.
  • SEM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.29% yearly.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.64% on average over the next years. This is a very strong growth
  • SEM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.74% yearly.
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.13 indicates a correct valuation of SEM.
  • Compared to the rest of the industry, the Price/Earnings ratio of SEM indicates a rather cheap valuation: SEM is cheaper than 84.16% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SEM to the average of the S&P500 Index (27.03), we can say SEM is valued slightly cheaper.
  • SEM is valuated correctly with a Price/Forward Earnings ratio of 12.27.
  • Based on the Price/Forward Earnings ratio, SEM is valued cheaper than 84.16% of the companies in the same industry.
  • SEM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.11.
Industry RankSector Rank
PE 14.13
Fwd PE 12.27
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SEM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SEM is cheaper than 80.20% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 72.28% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.16
EV/EBITDA 8
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • SEM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SEM's earnings are expected to grow with 21.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y15.26%
EPS Next 3Y21.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SEM Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.68%, SEM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, SEM pays a better dividend. On top of this SEM pays more dividend than 90.10% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 21.99% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP21.99%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (3/4/2026, 8:04:00 PM)

After market: 16.25 0 (0%)

16.25

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.91%
Inst Owner Change-3.76%
Ins Owners11.06%
Ins Owner Change0.41%
Market Cap2.01B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts77.78
Price Target17.88 (10.03%)
Short Float %3.39%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-3.49%
PT rev (3m)-3.49%
EPS NQ rev (1m)4.58%
EPS NQ rev (3m)4.58%
EPS NY rev (1m)0%
EPS NY rev (3m)2.41%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 14.13
Fwd PE 12.27
P/S 0.37
P/FCF 17.16
P/OCF 5.81
P/B 1.18
P/tB N/A
EV/EBITDA 8
EPS(TTM)1.15
EY7.08%
EPS(NY)1.32
Fwd EY8.15%
FCF(TTM)0.95
FCFY5.83%
OCF(TTM)2.8
OCFY17.22%
SpS44.04
BVpS13.77
TBVpS-6.11
PEG (NY)0.93
PEG (5Y)N/A
Graham Number18.88
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.62
F-Score5
WACC8.07%
ROIC/WACC0.65
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year43.55%
EBIT Next 3Y18.69%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 14.13 and the Price/Book (PB) ratio is 1.18.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.